Avestar Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.01M | Buy |
18,114
+4,296
| +31% | +$476K | 0.14% | 106 |
|
|
2025
Q1 | $1.55M | Buy |
13,818
+5,521
| +67% | +$619K | 0.13% | 114 |
|
|
2024
Q4 | $766K | Buy |
8,297
+1,362
| +20% | +$126K | 0.07% | 196 |
|
|
2024
Q3 | $581K | Buy |
6,935
+1,534
| +28% | +$129K | 0.06% | 223 |
|
|
2024
Q2 | $371K | Buy |
5,401
+568
| +12% | +$39K | 0.04% | 270 |
|
|
2024
Q1 | $354K | Sell |
4,833
-235
| -5% | -$17.2K | 0.04% | 277 |
|
|
2023
Q4 | $411K | Buy |
5,068
+1,274
| +34% | +$103K | 0.05% | 208 |
|
|
2023
Q3 | $284K | Buy |
3,794
+694
| +22% | +$52K | 0.04% | 243 |
|
|
2023
Q2 | $239K | Buy |
3,100
+596
| +24% | +$45.9K | 0.04% | 256 |
|
|
2023
Q1 | $208K | Sell |
2,504
-168
| -6% | -$13.9K | 0.04% | 264 |
|
|
2022
Q4 | $229K | Buy |
+2,672
| New | +$229K | 0.04% | 235 |
|
|
2021
Q2 | – | Sell |
-3,472
| Closed | -$224K | – | 375 |
|
|
2021
Q1 | $224K | Buy |
+3,472
| New | +$224K | 0.05% | 296 |
|
|
2020
Q3 | – | Sell |
-4,677
| Closed | -$360K | – | 235 |
|
|
2020
Q2 | $360K | Sell |
4,677
-7,476
| -62% | -$575K | 0.16% | 125 |
|
|
2020
Q1 | $909K | Buy |
12,153
+355
| +3% | +$26.6K | 0.5% | 49 |
|
|
2019
Q4 | $766K | Sell |
11,798
-325
| -3% | -$21.1K | 0.43% | 59 |
|
|
2019
Q3 | $768K | Buy |
12,123
+226
| +2% | +$14.3K | 0.48% | 47 |
|
|
2019
Q2 | $798K | Buy |
11,897
+5
| +0% | +$335 | 0.51% | 45 |
|
|
2019
Q1 | $769K | Buy |
11,892
+26
| +0.2% | +$1.68K | 0.51% | 44 |
|
|
2018
Q4 | $739K | Sell |
11,866
-2
| -0% | -$125 | 0.5% | 41 |
|
|
2018
Q3 | $913K | Sell |
11,868
-166
| -1% | -$12.8K | 0.53% | 34 |
|
|
2018
Q2 | $849K | Sell |
12,034
-9
| -0.1% | -$635 | 0.54% | 36 |
|
|
2018
Q1 | $904K | Buy |
12,043
+51
| +0.4% | +$3.83K | 0.59% | 29 |
|
|
2017
Q4 | $855K | Buy |
+11,992
| New | +$855K | 0.64% | 19 |
|